# Gentamicin

## Pharmacological Class

- **Class**: `Aminoglycoside` antibiotic
- **Type**: Bactericidal
- **Source**: Derived from _Micromonospora purpurea_

## Mechanism of Action

- **Inhibits bacterial protein synthesis**:
  → Binds irreversibly to **30S ribosomal subunit**
  → Misreading of mRNA → abnormal/nonfunctional proteins
  → Disrupts cell membrane → bactericidal effect
  → **Concentration-dependent killing** and **post-antibiotic effect**

## Indications

1. **Gram-negative bacterial infections**:

   - Septicaemia
   - Neonatal sepsis
   - Pyelonephritis
   - Intra-abdominal infections
   - Hospital-acquired pneumonia

2. **Gram-positive infections (with β-lactams)**:

   - Endocarditis (e.g., _Enterococcus_, _Streptococcus_)

3. **Topical use**:

   - Infected burns, wounds, conjunctivitis, otitis externa

## Contraindications

- Hypersensitivity to gentamicin or other aminoglycosides
- **Myasthenia gravis** (↓ neuromuscular transmission)
- **Caution in**:

  - Renal impairment
  - Pre-existing hearing loss
  - Elderly patients
  - Concurrent ototoxic or nephrotoxic drugs (e.g., loop diuretics)

## Side Effects

1. **Nephrotoxicity**

   - Dose-dependent, reversible
   - Tubular necrosis

2. **Ototoxicity**

   - Irreversible (vestibular > cochlear)
   - Tinnitus, vertigo, hearing loss

3. **Neuromuscular blockade**

   - Rare, especially with anesthesia or neuromuscular blockers

4. **Others**:

   - Rash, fever
   - Eosinophilia

## Route of Administration

- **IV (preferred)**
- **IM**
- **Topical** (eye/ear drops, creams)
- **Intrathecal** (rare, for meningitis)

## Dosage

### Adults:

- **IV/IM**: 5–7 mg/kg/day **once daily**
  or
  1–1.5 mg/kg every 8 hours (conventional dosing)
- **Endocarditis**: 3 mg/kg/day in 2–3 divided doses with β-lactam
- **Dose adjustment required in renal impairment**

### Children:

- **Neonates**:

  - 4–5 mg/kg **every 24–36 hr** (based on weight and age)

- **Infants/children**:

  - 5–7.5 mg/kg/day once daily

- Monitor **peak** (30–60 min after dose) and **trough** (just before next dose) levels

## Use in Pregnancy

- **Category D (US FDA)**
  → Crosses placenta
  → Risk of fetal ototoxicity and nephrotoxicity
  → Use **only if life-threatening or no safer alternative**

## Use in Lactating Mothers

- Excreted in breast milk in **low amounts**
- Poor oral absorption → **Generally safe** for infant
- Monitor infant for diarrhoea or thrush
